303 related articles for article (PubMed ID: 35994403)
21. Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis.
Pieper NT; Grossi CM; Chan WY; Loke YK; Savva GM; Haroulis C; Steel N; Fox C; Maidment ID; Arthur AJ; Myint PK; Smith TO; Robinson L; Matthews FE; Brayne C; Richardson K
Age Ageing; 2020 Oct; 49(6):939-947. PubMed ID: 32603415
[TBL] [Abstract][Full Text] [Related]
22. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
23. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
[TBL] [Abstract][Full Text] [Related]
24. Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80-plus population-based study.
Pasina L; Lucca U; Tettamanti M
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1696-1702. PubMed ID: 33098318
[TBL] [Abstract][Full Text] [Related]
25. Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
Ruxton K; Woodman RJ; Mangoni AA
Br J Clin Pharmacol; 2015 Aug; 80(2):209-20. PubMed ID: 25735839
[TBL] [Abstract][Full Text] [Related]
26. Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia.
Mohanannair Geethadevi G; Quinn TJ; George J; Anstey KJ; Bell JS; Sarwar MR; Cross AJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014885. PubMed ID: 37265424
[TBL] [Abstract][Full Text] [Related]
27. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
28. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review.
Salahudeen MS; Duffull SB; Nishtala PS
BMC Geriatr; 2015 Mar; 15():31. PubMed ID: 25879993
[TBL] [Abstract][Full Text] [Related]
29. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
30. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease.
Orgeta V; McDonald KR; Poliakoff E; Hindle JV; Clare L; Leroi I
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD011961. PubMed ID: 32101639
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for dementia in Parkinson's Disease - the overuse of anticholinergic drugs.
Malkiewicz JJ; Kasprzyk AG; Waksmundzki D; Węgrzynek J; Chmiela T; Siuda J
Neurol Neurochir Pol; 2023; 57(5):405-413. PubMed ID: 37357543
[TBL] [Abstract][Full Text] [Related]
32. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
[TBL] [Abstract][Full Text] [Related]
33. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
[TBL] [Abstract][Full Text] [Related]
34. Effect of anticholinergic burden on treatment modification, delirium and mortality in newly diagnosed dementia patients starting a cholinesterase inhibitor: A population-based study.
Ah YM; Suh Y; Jun K; Hwang S; Lee JY
Basic Clin Pharmacol Toxicol; 2019 Jun; 124(6):741-748. PubMed ID: 30511428
[TBL] [Abstract][Full Text] [Related]
35. Centrally-acting anticholinergic drugs- associations with mortality, hospitalisation and cognitive decline following dementia diagnosis in people receiving antidepressant and antipsychotic drugs.
Bishara D; Perera G; Harwood D; Taylor D; Sauer J; Funnell N; Gee S; Stewart R; Mueller C
Aging Ment Health; 2022 Sep; 26(9):1747-1755. PubMed ID: 34308718
[TBL] [Abstract][Full Text] [Related]
36. Potentially inappropriate medication use and mortality in patients with cognitive impairment.
Buckley E; Jonsson A; Flood Z; Lavelle M; O'Sullivan N; Nurdin N; Dowling P; Duggan E; Callaly E; Byrne C; McGreevy C; Duggan J; Kyne L; McCabe JJ
Eur J Clin Pharmacol; 2022 Dec; 78(12):2013-2020. PubMed ID: 36329311
[TBL] [Abstract][Full Text] [Related]
37. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
38. Animal-assisted therapy for dementia.
Lai NM; Chang SMW; Ng SS; Tan SL; Chaiyakunapruk N; Stanaway F
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31763689
[TBL] [Abstract][Full Text] [Related]
39. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
McCleery J; Abraham RP; Denton DA; Rutjes AW; Chong LY; Al-Assaf AS; Griffith DJ; Rafeeq S; Yaman H; Malik MA; Di Nisio M; Martínez G; Vernooij RW; Tabet N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011905. PubMed ID: 30383288
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]